Please assess the completion status of the following clinical trial:

Trial Title: Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or Female~* Ages 18-70~* Past-year major depressive disorder, dysthymic disorder, generalized anxiety disorder, post-traumatic stress disorder, obsessive-compulsive disorder, phobia, or panic disorder with or without agoraphobia, based on Mini-Neuropsychiatric Interview (MINI) structured interview, OR lifetime diagnosis of one of the above based on MINI with a self-report of currently receiving treatment (prescribed psychoactive medication, behavioral therapy, etc.)~* Report smoking 5 or more cigarettes per day for the past year~* Provide an intake breath Carbon Monoxide (CO) sample \> 8 ppm~* Be without current substance abuse/dependence other than nicotine~* Be sufficiently literate to complete the research-related tasks~* Be in good physical health without serious illness or change in health in the past 3 months as determined by the licensed medical professional at each site~* Not pregnant or nursing and report using oral, implant, patch, ring, intrauterine device (IUD), injection or barrier contraceptives or report being surgically sterile or post-menopausal~* Report no significant use of other tobacco or nicotine products within the past month (\> 9 days in the past 30)~Exclusion Criteria:~* Any prior regular use (used as primary cigarette outside of the laboratory) of Spectrum cigarettes (i.e., research cigarettes with reduced nicotine content)~* Exclusive use of roll-your-own cigarettes~* Planning to quit smoking in the next 30 days~* A quit attempt in the past 30 days resulting in \> 3 days of abstinence~* Positive toxicology screen for illicit drugs not including marijuana (participants with valid prescriptions will not be excluded and participants with a positive toxicology screen will be allowed to re-screen once)~* Breath alcohol level \> 0.01 (participants with a positive screen will be allowed to re-screen once)~* Self-report of binge drinking alcohol (\> 9 days in the past 30, 4/5 drinks in 2 hours for women/men~* Systolic blood pressure below 90 mmHg or greater than or equal to 160 mmHg (participants outside the range will be allowed to re-screen once)~* Diastolic blood pressure below 50 mmHg or greater than or equal to 100 mmHg (participants outside the range will be allowed to re-screen once)~* Breath CO \> 80 ppm~* Heart rate below 45 or greater than or equal to 115 bpm (participants outside the range will be allowed to re-screen once)~* Currently seeking treatment for smoking cessation~* Have used nicotine replacement, bupropion or other pharmacotherapies as cessation aids in the past month (bupropion for treatment of depression will be allowed)~* Unstable psychiatric conditions (psychiatric medication changes in the past 4 weeks)~* Current symptoms of psychosis, dementia or mania~* Suicidal ideation in past month~* Suicide attempt in past 6 months~* Participation in another research study in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- 0.8 mg nicotine (Type: EXPERIMENTAL): 0.8 mg nicotine cigarettes
- 0.12 mg nicotine (Type: EXPERIMENTAL): 0.12 mg nicotine cigarettes
- 0.03 mg nicotine (Type: EXPERIMENTAL): 0.03 mg nicotine cigarettes

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete